We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$48.3B
AUM Growth
+$4.2B
Cap. Flow
-$749M
Cap. Flow %
-1.55%
Top 10 Hldgs %
25.22%
Holding
973
New
114
Increased
273
Reduced
385
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 25.57%
2 Healthcare 16.39%
3 Financials 11.55%
4 Consumer Discretionary 10.38%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UAL icon
726
United Airlines
UAL
$41.9B
$2.83M 0.01%
+68,609
New +$2.7M
DTM icon
727
DT Midstream
DTM
$13.6B
$2.74M 0.01%
50,000
WHD icon
728
Cactus
WHD
$5.5B
$2.72M 0.01%
60,000
-10,000
-14% -$455K
NGNE icon
729
Neurogene
NGNE
$710M
$2.63M 0.01%
135,581
+58,081
+75% +$832K
VAXX
730
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$2.55M 0.01%
3,000,000
CYTK icon
731
Cytokinetics
CYTK
$11B
$2.5M 0.01%
+30,000
New +$1.09M
TWKS
732
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$2.41M 0.01%
500,100
-599,900
-55% -$2.46M
WWD icon
733
Woodward
WWD
$21.6B
$2.39M 0.01%
17,587
-116,219
-87% -$15.2M
ALXO icon
734
ALX Oncology
ALXO
$284M
$2.38M ﹤0.01%
+160,000
New +$1.52M
SOC.WS
735
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$2.28M ﹤0.01%
1,183,334
-763,233
-39% -$698K
EGP icon
736
EastGroup Properties
EGP
$10.8B
$2.27M ﹤0.01%
+12,380
New +$2.11M
DAWN
737
DELISTED
Day One Biopharmaceuticals
DAWN
$2.19M ﹤0.01%
150,000
-886,599
-86% -$10.7M
IART icon
738
Integra LifeSciences
IART
$1.33B
$2.18M ﹤0.01%
+50,000
New +$1.97M
ARQ icon
739
Arq
ARQ
$90.6M
$2.16M ﹤0.01%
725,000
-25,000
-3% -$55.8K
SYM icon
740
Symbotic
SYM
$5.04B
$2.05M ﹤0.01%
40,000
-54,150
-58% -$2.37M
OTIS icon
741
Otis Worldwide
OTIS
$28.1B
$2.02M ﹤0.01%
22,586
-751,800
-97% -$62.5M
TFII icon
742
TFI International
TFII
$11.3B
$1.98M ﹤0.01%
+14,584
New +$1.73M
L icon
743
Loews
L
$23.7B
$1.93M ﹤0.01%
27,800
-156,100
-85% -$10.4M
MNDY icon
744
monday.com
MNDY
$3.7B
$1.88M ﹤0.01%
10,000
-30,000
-75% -$4.83M
FROG icon
745
JFrog
FROG
$10.1B
$1.73M ﹤0.01%
50,000
-25,000
-33% -$676K
THRD
746
DELISTED
Third Harmonic Bio
THRD
$1.67M ﹤0.01%
152,027
-40,000
-21% -$317K
ARCH
747
DELISTED
Arch Resources, Inc.
ARCH
$1.66M ﹤0.01%
10,000
-120,000
-92% -$18.9M
CRVO icon
748
CervoMed
CRVO
$25.6M
$1.52M ﹤0.01%
199,347
VTYX
749
DELISTED
Ventyx Biosciences
VTYX
$1.48M ﹤0.01%
600,000
-387,970
-39% -$3.68M
BCAB icon
750
BioAtla
BCAB
$5.53M
$1.48M ﹤0.01%
12,000
-23,923
-67% -$2.07M

Similar funds

Adage Capital Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Adage Capital Partners held 973 positions worth $48.3B, up 9.5% from $44.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Adage Capital Partners's Q4 2023 filing shows 114 new, 273 increased, 385 reduced and 131 closed positions. Its largest new stake was Uber: 2,148,900 shares worth $132M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q4 2023 buy was Uber: 2,148,900 shares worth $132M.
  • Adage Capital Partners added most to Hess in Q4 2023, an estimated $516M increase.
  • Adage Capital Partners's biggest Q4 2023 reduction was lululemon athletica, cutting an estimated $124M.
  • Adage Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $340M.
  • Adage Capital Partners's ten largest holdings make up 25% of its $48.3B portfolio in Q4 2023.
  • Adage Capital Partners opened 114 new positions and closed 131 in Q4 2023.
  • Adage Capital Partners's portfolio value rose 9.5% quarter-over-quarter to $48.3B.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.